This infographic covers
- Number of assets in each trial phase and, the typical pattern that emerges when looking at the highest phase of development
- Clinical growth through the distribution of the number of trials over time
- Trials that have been withdrawn since 2011 with reasoning
Find out more
Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies, combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug and trial landscape.
With Beacon, you can make drug development decisions with confidence. This is why 23 of the world’s top 25 drug developers trust us.
Speak with our Team
Our dedicated account and research teams can help you with questions by showing you how this insight and data is collated on Beacon.